0001354488-16-005954.txt : 20160121 0001354488-16-005954.hdr.sgml : 20160121 20160121211027 ACCESSION NUMBER: 0001354488-16-005954 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160119 FILED AS OF DATE: 20160121 DATE AS OF CHANGE: 20160121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cellular Biomedicine Group, Inc. CENTRAL INDEX KEY: 0001378624 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 861032927 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 19925 STEVENS CREEK BLVD., SUITE 100 CITY: CUPERTINO STATE: CA ZIP: 95014 BUSINESS PHONE: (408) 973-7884 MAIL ADDRESS: STREET 1: 19925 STEVENS CREEK BLVD., SUITE 100 CITY: CUPERTINO STATE: CA ZIP: 95014 FORMER COMPANY: FORMER CONFORMED NAME: EastBridge Investment Group Corp DATE OF NAME CHANGE: 20061019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chan Andrew K CENTRAL INDEX KEY: 0001569877 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36498 FILM NUMBER: 161354601 MAIL ADDRESS: STREET 1: 530 UNIVERSITY AVENUE, #17 CITY: PALO ALTO STATE: CA ZIP: 94301 4 1 issuerdirect_section16.xml PRIMARY DOCUMENT X0306 4 2016-01-19 0 0001378624 Cellular Biomedicine Group, Inc. CBMG 0001569877 Chan Andrew K 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014 1 SVP Corp Bus Dev Common Stock 2016-01-19 4 M 0 1516 5.61 A 147273 D Common Stock 2016-01-19 4 S 0 1516 12.07 D 145757 D Common Stock 2016-01-21 4 M 0 1296 3.00 A 147053 D Common Stock 2016-01-21 4 S 0 1296 13.87 D 145747 D Non- Qualified Stock Option (right to buy) (2013 Plan) 5.61 2016-01-19 4 M 0 1516 0 D 2023-05-16 Common Stock 1516 39420 D Non- Qualified Stock Option (right to buy) (2011 Plan) 3.00 2016-01-21 4 M 0 1296 0 D 2023-02-20 Common Stock 1296 40187 D The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2015. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. On December 22, 2015, due to miscommunications with regard to the nature of transactions undertaken by the reporting person in September 2015, the reporting person mistakenly reported the number of shares of common stock and derivative securities of the issuer owned by him after certain transactions undertaken in December 2015. As a result, the number of outstanding securities owned by the reporting person after each transaction as reported on this form reflects corrections of the reporting errors made in December 2015. The option vested according to the following schedule: 1/31st per month following the vesting commencement date of May 16, 2014. The option vested according to the following schedule: 1/36th per month following the vesting commencement date of February 20, 2013. /s/ Andrew Chan 2016-01-21